Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 10:22 PM
Study NCT ID:
NCT05971758
Status:
RECRUITING
Last Update Posted:
2025-07-04
First Post:
2023-07-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
Sponsor:
University of California, Los Angeles
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-16
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-06
First Submit QC Date:
None
Study First Post Date:
2023-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-01
Last Update Post Date:
2025-07-04
Last Update Post Date Type:
ACTUAL